1. Home
  2. ABCL vs KALU Comparison

ABCL vs KALU Comparison

Compare ABCL & KALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$12.61

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Logo Kaiser Aluminum Corporation

KALU

Kaiser Aluminum Corporation

HOLD

Current Price

$151.85

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
KALU
Founded
2012
1946
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.0B
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
ABCL
KALU
Price
$12.61
$151.85
Analyst Decision
Strong Buy
Hold
Analyst Count
5
3
Target Price
$8.40
$147.33
AVG Volume (30 Days)
4.4M
145.9K
Earning Date
05-11-2026
04-22-2026
Dividend Yield
N/A
1.78%
EPS Growth
10.91
135.89
EPS
N/A
9.43
Revenue
$75,128,000.00
$1,585,900,000.00
Revenue This Year
N/A
$13.37
Revenue Next Year
$21.85
$2.62
P/E Ratio
N/A
$16.01
Revenue Growth
160.56
N/A
52 Week Low
$2.75
$73.08
52 Week High
$13.18
$199.89

Technical Indicators

Market Signals
Indicator
ABCL
KALU
Relative Strength Index (RSI) 65.97 42.11
Support Level $10.38 $116.89
Resistance Level N/A $196.37
Average True Range (ATR) 0.61 5.67
MACD -0.01 -0.54
Stochastic Oscillator 79.02 17.68

Price Performance

Historical Comparison
ABCL
KALU

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About KALU Kaiser Aluminum Corporation

Kaiser Aluminum Corp specializes in the production of semi-fabricated specialty aluminum mill products, such as aluminum plate and sheet, bare and coated coil and extruded and drawn products, for the end market applications: Aero/HS Products; Packaging; GE Products; and Automotive Extrusions. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.

Share on Social Networks: